Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure

被引：0
|
作者：
Gustav Mattsson
Marita Wallhagen
Peter Magnusson
机构：
[1] Uppsala University/Region Gävleborg,Centre for Research and Development
[2] University of Gävle,Department of Building Engineering, Energy Systems and Sustainability Science
[3] Karolinska Institutet,Cardiology Research Unit, Department of Medicine
来源：
BMC Cardiovascular Disorders | / 21卷
关键词：
Cardiomyopathy; Heart failure; Implantable cardioverter defibrillator; Kansas City Cardiomyopathy Questionnaire; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] ASSESSMENT OF IMPACT OF SLEEP DISORDERS/SYMPTOMS ON THE HEALTH STATUS OF HEART FAILURE (HF) PATIENTS USING KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE (KCCQ)
    Sriubiene, I
    Foldvary-Schaefer, N.
    Baccaray, S.
    Andrews, N.
    Alsheiktaha, Z.
    SLEEP, 2009, 32 : A322 - A323
  • [22] USEFULNESS OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN PRIMARY VERSUS SECONDARY PREVENTION IN PATIENTS WITH ISCHEMIC AND NON ISCHEMIC CARDIOMYOPATHY
    Marti-Almor, J.
    Bazan, V.
    Oliva, X.
    Cian, D.
    Delclos, J.
    Corral, M.
    Mojal, S.
    Bruguera, J.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2009, 20 : S12 - S13
  • [23] Predictors of Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy in Primary Prevention Patients with Ischemic and Nonischemic Cardiomyopathy
    Verma, Atul
    Sarak, Bradley
    Kaplan, Alexander J.
    Oosthuizen, Richard
    Beardsall, Marianne
    Wulffhart, Zaev
    Higenbottam, Janet
    Khaykin, Yaariv
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2010, 33 (03): : 320 - 329
  • [24] Effect of primary prevention of implantable cardioverter defibrillator on sudden cardiac death in 24 patients with dilated cardiomyopathy
    弓旭东
    China Medical Abstracts(Internal Medicine), 2017, 34 (01) : 32 - 33
  • [25] SURVIVAL OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) RECIPIENT FOR PRIMARY PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE
    Joncas, S. X.
    Ayala-Paredes, F. A.
    Carrier, N.
    Farand, P.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S342 - S342
  • [26] Appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischemic and non-ischemic cardiomyopathy
    Mattsson, G.
    Kader, R.
    Pournaras, A.
    Magnusson, P.
    EUROPEAN HEART JOURNAL, 2018, 39 : 216 - 216
  • [27] Reliability and Validity of Kansas City Cardiomyopathy Questionnaire in Arabic Patients with Chronic Heart Failure
    Albarrati, Ali M.
    Altimani, Rayan
    Almogbel, Osama
    Alnahdi, Ali H.
    Almurdi, Muneera M.
    Abuammah, Aliah
    Nazer, Rakan
    MEDICINA-LITHUANIA, 2023, 59 (11):
  • [28] Relationships among the Kansas City cardiomyopathy questionnaire and clinical measures in patients with heart failure
    Flynn, Kathryn E.
    Lin, Li
    Ellis, Stephen
    Fine, Lawrence
    Pina, Ileana
    Roll, Susan Kay
    Russell, Stuart
    Schulman, Kevin
    Spertus, John
    Whelan, David
    Weinfurt, Kevin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A269 - A269
  • [29] Validity, reliability, and responsiveness of the Kansas City Cardiomyopathy Questionnaire in anemic heart failure patients
    John A. Spertus
    Philip G. Jones
    John Kim
    Denise Globe
    Quality of Life Research, 2008, 17 : 291 - 298
  • [30] Validity, reliability, and responsiveness of the Kansas City Cardiomyopathy Questionnaire in anemic heart failure patients
    Spertus, John A.
    Jones, Philip G.
    Kim, John
    Globe, Denise
    QUALITY OF LIFE RESEARCH, 2008, 17 (02) : 291 - 298
12345